AMGN

Amgen Inc. · VIE:AMGN

423.00 EUR11.50 +2.79%

Amgen Inc. (VIE:AMGN) last traded at 423.00 EUR, up 2.79% on the day. Over the past year the stock is up 68.16%. Its 52-week range is 255.10 to 423.55. It is in the Health Technology sector (Biotechnology).

Key statistics

Open420.25

Day range420.25 – 423.55

52-week range255.10 – 423.55

Volume0

Average volume (10 days)10

Market cap (USD)251.94 B

P/E30.01

EPS (TTM) (USD)16.10

Dividend yield2.13%

Beta (1 year)−0.0453

Revenue (TTM) (USD)38.20 B

Employees31.50 K

Performance

+6.09%1 week

+13.00%1 month

+26.23%3 months

+46.85%6 months

+52.13%Year to date

+68.16%1 year

Technical rating

Strong buy

Daily summary of 11 oscillators and 15 moving averages. See every indicator

Analysts’ target

363.27 EUR

The average 1-year price target, −14.12% from the last price. See the forecast

Latest headlines

Amgen (AMGN) reports Q3: everything you need to know ahead of earningsStock Story · 02 Nov 2026
Jobs, Midterm Elections, Apple, Palantir, McDonald's, Moderna, and More to Watch This Week — Barrons.comDow Jones Newswires · 01 Nov 2026
Healthcare Earnings Scoreboard: 96% beat EPS estimates, 70% post Y/Y earnings growthSeeking Alpha · 31 Oct 2026
Big Homes, Big Loans — Barrons.comDow Jones Newswires · 30 Oct 2026
Catalyst watch: Election drama, jobs report, Apple and McDonald's in the earnings confessionalSeeking Alpha · 30 Oct 2026
Steve Jobs' Son Says GLP-1 Weight Loss Drugs Could Be Among Most Important Medicines Ever, With Potential Impact on CancerBenzinga · 29 Oct 2026
Amgen Q3 Earnings: Will Strong Drug Sales Offset Headwinds?Zacks · 28 Oct 2026
FDA warns Amgen over cancer drug promotional videoReuters · 28 Oct 2026

Market data from TradingView’s public feed, delayed as the exchange requires. For study only, not investment advice.